At the single-cell level, PAX7 target gene repression can discriminate FSHD cells from controls, even when these cells are DUX4 target gene negative, suggesting that this biomarker may be of greater use than DUX4 target gene expression. The gene discussed is PAX7; the disease is facioscapulohumeral muscular dystrophy.